CompanyDrug

Dr. Reddy’s Launches Biosimilar Versavo in UK to Challenge Roche’s Cancer Therapy Avastin

CompanyDrug

Bayer’s Elinzanetant Achieves Primary Endpoint in Late-Stage Menopause Symptom Trial

CompanyDrug

China Medical System Gets Green Light for Phase III Clinical Trial of Opzelura in Atopic Dermatitis

CompanyDrug

AstraZeneca’s Lynparza-Imfinzi Combo Shows Promising Results in Endometrial Cancer Study

Policy / Regulatory

China’s National Joint Procurement Office Sets March 2024 for Insulin Contracts Renewal

Company

WuXi AppTec Posts Modest Revenue Growth Despite Regulatory Hurdles

CompanyDrug

Teruisi Pharma’s TRS005 Receives Support for Breakthrough Designation in China for CD20-Positive Lymphoma

CompanyDrug

Pfizer’s Elrexfio Anticipated for Priority Review in China for Relapsed/Refractory Multiple Myeloma

Policy / Regulatory

CDE Seeks Public Feedback on Latest Batch of Generic Drug Reference Preparations

CompanyDrug

AstraZeneca Caps Monthly Costs for US Patients with Asthma and COPD Inhalers

CompanyDrug

Jiangsu Yahong Meditech to Present Phase III Results for Cervical Cancer Treatment at SGO Annual Meeting

CompanyMedical Device

Sino Medical Sciences Secures South Korean Approvals for Three Cardiovascular Devices